ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate
July 06, 2021Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, today announced the completion of ... -
European Pharmacopoeia adopts revised Raman spectroscopy chapter
May 14, 2021The revised Raman Spectroscopy chapter (2.2.48) will be released in October, with updates focusing on enhancing the reliability of the results. -
First Participants Dosed in Adjuvanted S-Trimer COVID-19 Vaccine Candidate Trial
April 01, 2021Clover Biopharmaceuticals and Dynavax Technologies announced the first participants have been dosed in Clover's SPECTRA trial (Study Evaluating Protective-Efficacy and Safety of Clover's Trimeric Recombinant Protein-based and Adjuvanted COVID-19 ... -
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
March 25, 2021Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating diseases, and Dynavax Technologies Corporation, a biopharmaceutical ... -
Using machine learning to interpret material spectra
September 10, 2018Researchers from the University of Tokyo have developed a method to use machine learning to interpret data from spectroscopy techniques…
Pharma Sources Insight January 2025
